| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d09fcfbc4a7b8d02a2b5504f2a54009e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate |
1999-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e75cf8252f0e4017feff802975d5a3c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20cef078c040a61c71e242138f604ca4 |
| publicationDate |
1999-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9944632-A1 |
| titleOfInvention |
Treatment of fibromyalgia with low interferon doses |
| abstract |
A method is described for using interferon in the treatment of human patients afflicted with fibromyalgia to alleviate one or more symptoms associated with that disease state. Fibromyalgia positive patients treated bucally, sublingually or by oral ingestion administration of low doses of interferon enjoy a reduction in clinical symptoms of the disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1221976-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1221976-A4 |
| priorityDate |
1998-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |